Related Experiment Video
Updated: Jun 17, 2026
06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
The second Geneva Consensus: Recommendations for novel live TB vaccines.
K B Walker1, M J Brennan, M M Ho
1HPA-NIBSC, Blanche Lane, South Mimms, Potters Bar, UK. Barry.Walker@nibsc.hpa.org.uk
Vaccine
|January 16, 2010
Summary
Developing new live tuberculosis (TB) vaccines, including attenuated Mycobacterium tuberculosis, is a priority. The second Geneva Consensus addressed regulatory and clinical development needs for these novel TB vaccines.
Area of Science:
- Vaccinology
- Microbiology
- Public Health
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in developing nations.
- Live mycobacterial vaccines, such as recombinant BCG and attenuated Mycobacterium tuberculosis, are promising strategies for TB control.
- Previous consensus guidelines (2005) outlined initial requirements for live TB vaccine development.
Framework:
- The second Geneva Consensus (2009) focused on regulatory pathways for live TB vaccines entering Phase I trials.
- Key considerations included characterization, safety, attenuation, antibiotic resistance markers, and vaccine phenotypes.
- Criteria for progression from Phase I through Phase III clinical development were identified.
Implementation:
- Regulatory landscapes in developing countries for Phase II and III trials were reviewed.
- Manufacturing considerations for live TB vaccines were discussed, referencing WHO and European Pharmacopeia guidelines for BCG.
- Integration of new TB vaccines into existing BCG vaccination programs was addressed.
Implications:
- This consensus provides a roadmap for advancing novel live TB vaccines through clinical trials and regulatory approval.
- Addressing regulatory and manufacturing challenges is crucial for the successful implementation of new TB vaccines.
- Harmonizing requirements will facilitate global access to effective TB prevention strategies.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...